Oncolytic Virus Market Report

Europe Oncolytic Virus Market Size, Status and Forecast 2014-2026

  • POSTDATE：Mar 27, 2020
  • PAGES：179
  • REPORT CODE：GMM523290
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Oncolytic Virus market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.9% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Oncolytic Virus Market Segmentations:

    By Player:

    • Roche

    • Takara Bio

    • Theravir

    • Otsuka Pharmaceutical Co

    • Merck

    • SillaJen

    • Latima

    • Shanghai Sunway Biotech

    • Pfizer

    • Genelux

    • Neotropix

    • Cold Genesys

    By Type:

    • HSV-based Oncolytic Viruses

    • Adenoviruses-based Oncolytic Viruses

    • Vaccinia Virus-based Oncolytic Viruses

    • Vesicular Stomatitis Virus-based Oncolytic Viruses

    • Newcastle Disease Virus-based Oncolytic Viruses

    By End-User:

    • Pharmaceutical

    • Health Care

    • Commerical

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Oncolytic Virus Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Oncolytic Virus Market Size and Growth Rate of HSV-based Oncolytic Viruses from 2014 to 2026

    • 1.3.2 Europe Oncolytic Virus Market Size and Growth Rate of Adenoviruses-based Oncolytic Viruses from 2014 to 2026

    • 1.3.3 Europe Oncolytic Virus Market Size and Growth Rate of Vaccinia Virus-based Oncolytic Viruses from 2014 to 2026

    • 1.3.4 Europe Oncolytic Virus Market Size and Growth Rate of Vesicular Stomatitis Virus-based Oncolytic Viruses from 2014 to 2026

    • 1.3.5 Europe Oncolytic Virus Market Size and Growth Rate of Newcastle Disease Virus-based Oncolytic Viruses from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Oncolytic Virus Market Size and Growth Rate of Pharmaceutical from 2014 to 2026

    • 1.4.2 Europe Oncolytic Virus Market Size and Growth Rate of Health Care from 2014 to 2026

    • 1.4.3 Europe Oncolytic Virus Market Size and Growth Rate of Commerical from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Oncolytic Virus Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Oncolytic Virus by Major Types

      • 3.4.1 Market Size and Growth Rate of HSV-based Oncolytic Viruses

      • 3.4.2 Market Size and Growth Rate of Adenoviruses-based Oncolytic Viruses

      • 3.4.3 Market Size and Growth Rate of Vaccinia Virus-based Oncolytic Viruses

      • 3.4.4 Market Size and Growth Rate of Vesicular Stomatitis Virus-based Oncolytic Viruses

      • 3.4.5 Market Size and Growth Rate of Newcastle Disease Virus-based Oncolytic Viruses

    4 Segmentation of Oncolytic Virus Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Oncolytic Virus by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Oncolytic Virus for Pharmaceutical

      • 4.4.2 Market Size and Growth Rate of Oncolytic Virus for Health Care

      • 4.4.3 Market Size and Growth Rate of Oncolytic Virus for Commerical

    5 Market Analysis by Major Regions

    • 5.1 Europe Oncolytic Virus Production Analysis by Top Regions

    • 5.2 Europe Oncolytic Virus Consumption Analysis by Top Regions

    • 5.3 Europe Oncolytic Virus Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Oncolytic Virus Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Oncolytic Virus Production, Import, Consumption and Export Analysis

      • 5.3.3 France Oncolytic Virus Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Oncolytic Virus Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Oncolytic Virus Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Oncolytic Virus Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Oncolytic Virus Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Oncolytic Virus Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Oncolytic Virus Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncolytic Virus Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Oncolytic Virus Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Oncolytic Virus Production, Import, Consumption and Export Analysis

    6 Product Circulation of Oncolytic Virus Market among Top Countries

    • 6.1 Top 5 Export Countries in Oncolytic Virus Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Oncolytic Virus Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Oncolytic Virus Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Oncolytic Virus Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Oncolytic Virus Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Oncolytic Virus Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Oncolytic Virus Landscape Analysis

    • 7.1 Germany Oncolytic Virus Landscape Analysis by Major Types

    • 7.2 Germany Oncolytic Virus Landscape Analysis by Major End-Users

    8. UK Oncolytic Virus Landscape Analysis

    • 8.1 UK Oncolytic Virus Landscape Analysis by Major Types

    • 8.2 UK Oncolytic Virus Landscape Analysis by Major End-Users

    9. France Oncolytic Virus Landscape Analysis

    • 9.1 France Oncolytic Virus Landscape Analysis by Major Types

    • 9.2 France Oncolytic Virus Landscape Analysis by Major End-Users

    10. Italy Oncolytic Virus Landscape Analysis

    • 10.1 Italy Oncolytic Virus Landscape Analysis by Major Types

    • 10.2 Italy Oncolytic Virus Landscape Analysis by Major End-Users

    11. Spain Oncolytic Virus Landscape Analysis

    • 11.1 Spain Oncolytic Virus Landscape Analysis by Major Types

    • 11.2 Spain Oncolytic Virus Landscape Analysis by Major End-Users

    12. Poland Oncolytic Virus Landscape Analysis

    • 12.1 Poland Oncolytic Virus Landscape Analysis by Major Types

    • 12.2 Poland Oncolytic Virus Landscape Analysis by Major End-Users

    13. Russia Oncolytic Virus Landscape Analysis

    • 13.1 Russia Oncolytic Virus Landscape Analysis by Major Types

    • 13.2 Russia Oncolytic Virus Landscape Analysis by Major End-Users

    14. Switzerland Oncolytic Virus Landscape Analysis

    • 14.1 Switzerland Oncolytic Virus Landscape Analysis by Major Types

    • 14.2 Switzerland Oncolytic Virus Landscape Analysis by Major End-Users

    15. Turkey Oncolytic Virus Landscape Analysis

    • 15.1 Turkey Oncolytic Virus Landscape Analysis by Major Types

    • 15.2 Turkey Oncolytic Virus Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncolytic Virus Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncolytic Virus Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncolytic Virus Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncolytic Virus Landscape Analysis by Top Countries

      • 16.3.1 Denmark Oncolytic Virus Market Volume and Growth Rate

      • 16.3.2 Finland Oncolytic Virus Market Volume and Growth Rate

      • 16.3.3 Norway Oncolytic Virus Market Volume and Growth Rate

      • 16.3.4 Sweden Oncolytic Virus Market Volume and Growth Rate

      • 16.3.6 Iceland Oncolytic Virus Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Oncolytic Virus Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Oncolytic Virus Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Oncolytic Virus Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Oncolytic Virus Landscape Analysis by Top Countries

      • 17.3.1 Belgium Oncolytic Virus Market Volume and Growth Rate

      • 17.3.2 Netherlands Oncolytic Virus Market Volume and Growth Rate

      • 17.3.3 Luxembourg Oncolytic Virus Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Oncolytic Virus Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Oncolytic Virus Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Oncolytic Virus Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Oncolytic Virus Landscape Analysis by Top Countries

      • 18.3.1 Estonia Oncolytic Virus Market Volume and Growth Rate

      • 18.3.2 Latvia Oncolytic Virus Market Volume and Growth Rate

      • 18.3.3 Lithuania Oncolytic Virus Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Roche

      • 19.1.1 Roche Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Takara Bio

      • 19.2.1 Takara Bio Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Theravir

      • 19.3.1 Theravir Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Otsuka Pharmaceutical Co

      • 19.4.1 Otsuka Pharmaceutical Co Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Merck

      • 19.5.1 Merck Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 SillaJen

      • 19.6.1 SillaJen Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Latima

      • 19.7.1 Latima Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Shanghai Sunway Biotech

      • 19.8.1 Shanghai Sunway Biotech Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Pfizer

      • 19.9.1 Pfizer Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Genelux

      • 19.10.1 Genelux Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Neotropix

      • 19.11.1 Neotropix Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Cold Genesys

      • 19.12.1 Cold Genesys Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    The List of Tables and Figures (Totals 90 Figures and 130 Tables)

    • Figure Product Picture

    • Figure Europe Oncolytic Virus Market Size and Growth Rate of HSV-based Oncolytic Viruses from 2014 to 2026

    • Figure Europe Oncolytic Virus Market Size and Growth Rate of Adenoviruses-based Oncolytic Viruses from 2014 to 2026

    • Figure Europe Oncolytic Virus Market Size and Growth Rate of Vaccinia Virus-based Oncolytic Viruses from 2014 to 2026

    • Figure Europe Oncolytic Virus Market Size and Growth Rate of Vesicular Stomatitis Virus-based Oncolytic Viruses from 2014 to 2026

    • Figure Europe Oncolytic Virus Market Size and Growth Rate of Newcastle Disease Virus-based Oncolytic Viruses from 2014 to 2026

    • Figure Europe Oncolytic Virus Market Size and Growth Rate of Pharmaceutical from 2014 to 2026

    • Figure Europe Oncolytic Virus Market Size and Growth Rate of Health Care from 2014 to 2026

    • Figure Europe Oncolytic Virus Market Size and Growth Rate of Commerical from 2014 to 2026

    • Figure Germany Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

    • Figure UK Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

    • Figure France Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Oncolytic Virus Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Oncolytic Virus Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Oncolytic Virus

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Oncolytic Virus by Different Types from 2014 to 2026

    • Table Consumption Share of Oncolytic Virus by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of HSV-based Oncolytic Viruses

    • Figure Market Size and Growth Rate of Adenoviruses-based Oncolytic Viruses

    • Figure Market Size and Growth Rate of Vaccinia Virus-based Oncolytic Viruses

    • Figure Market Size and Growth Rate of Vesicular Stomatitis Virus-based Oncolytic Viruses

    • Figure Market Size and Growth Rate of Newcastle Disease Virus-based Oncolytic Viruses

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Oncolytic Virus by Different End-Users from 2014 to 2026

    • Table Consumption Share of Oncolytic Virus by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Pharmaceutical

    • Figure Market Size and Growth Rate of Health Care

    • Figure Market Size and Growth Rate of Commerical

    • Table Europe Oncolytic Virus Production by Major Regions

    • Table Europe Oncolytic Virus Production Share by Major Regions

    • Figure Europe Oncolytic Virus Production Share by Major Countries and Regions in 2014

    • Table Europe Oncolytic Virus Consumption by Major Regions

    • Table Europe Oncolytic Virus Consumption Share by Major Regions

    • Table Germany Oncolytic Virus Production, Import, Consumption and Export Analysis

    • Table UK Oncolytic Virus Production, Import, Consumption and Export Analysis

    • Table France Oncolytic Virus Production, Import, Consumption and Export Analysis

    • Table Italy Oncolytic Virus Production, Import, Consumption and Export Analysis

    • Table Spain Oncolytic Virus Production, Import, Consumption and Export Analysis

    • Table Poland Oncolytic Virus Production, Import, Consumption and Export Analysis

    • Table Russia Oncolytic Virus Production, Import, Consumption and Export Analysis

    • Table Switzerland Oncolytic Virus Production, Import, Consumption and Export Analysis

    • Table Turkey Oncolytic Virus Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncolytic Virus Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oncolytic Virus Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oncolytic Virus Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Oncolytic Virus Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Oncolytic Virus Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Oncolytic Virus Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Oncolytic Virus Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Oncolytic Virus Consumption by Types from 2014 to 2026

    • Table Germany Oncolytic Virus Consumption Share by Types from 2014 to 2026

    • Table Germany Oncolytic Virus Consumption by End-Users from 2014 to 2026

    • Table Germany Oncolytic Virus Consumption Share by End-Users from 2014 to 2026

    • Table UK Oncolytic Virus Consumption by Types from 2014 to 2026

    • Table UK Oncolytic Virus Consumption Share by Types from 2014 to 2026

    • Table UK Oncolytic Virus Consumption by End-Users from 2014 to 2026

    • Table UK Oncolytic Virus Consumption Share by End-Users from 2014 to 2026

    • Table France Oncolytic Virus Consumption by Types from 2014 to 2026

    • Table France Oncolytic Virus Consumption Share by Types from 2014 to 2026

    • Table France Oncolytic Virus Consumption by End-Users from 2014 to 2026

    • Table France Oncolytic Virus Consumption Share by End-Users from 2014 to 2026

    • Table Italy Oncolytic Virus Consumption by Types from 2014 to 2026

    • Table Italy Oncolytic Virus Consumption Share by Types from 2014 to 2026

    • Table Italy Oncolytic Virus Consumption by End-Users from 2014 to 2026

    • Table Italy Oncolytic Virus Consumption Share by End-Users from 2014 to 2026

    • Table Spain Oncolytic Virus Consumption by Types from 2014 to 2026

    • Table Spain Oncolytic Virus Consumption Share by Types from 2014 to 2026

    • Table Spain Oncolytic Virus Consumption by End-Users from 2014 to 2026

    • Table Spain Oncolytic Virus Consumption Share by End-Users from 2014 to 2026

    • Table Poland Oncolytic Virus Consumption by Types from 2014 to 2026

    • Table Poland Oncolytic Virus Consumption Share by Types from 2014 to 2026

    • Table Poland Oncolytic Virus Consumption by End-Users from 2014 to 2026

    • Table Poland Oncolytic Virus Consumption Share by End-Users from 2014 to 2026

    • Table Russia Oncolytic Virus Consumption by Types from 2014 to 2026

    • Table Russia Oncolytic Virus Consumption Share by Types from 2014 to 2026

    • Table Russia Oncolytic Virus Consumption by End-Users from 2014 to 2026

    • Table Russia Oncolytic Virus Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Oncolytic Virus Consumption by Types from 2014 to 2026

    • Table Switzerland Oncolytic Virus Consumption Share by Types from 2014 to 2026

    • Table Switzerland Oncolytic Virus Consumption by End-Users from 2014 to 2026

    • Table Switzerland Oncolytic Virus Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Oncolytic Virus Consumption by Types from 2014 to 2026

    • Table Turkey Oncolytic Virus Consumption Share by Types from 2014 to 2026

    • Table Turkey Oncolytic Virus Consumption by End-Users from 2014 to 2026

    • Table Turkey Oncolytic Virus Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncolytic Virus Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncolytic Virus Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncolytic Virus Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncolytic Virus Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncolytic Virus Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncolytic Virus Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Oncolytic Virus Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Oncolytic Virus Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Oncolytic Virus Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Oncolytic Virus Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Oncolytic Virus Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oncolytic Virus Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oncolytic Virus Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oncolytic Virus Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oncolytic Virus Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oncolytic Virus Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oncolytic Virus Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Oncolytic Virus Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Oncolytic Virus Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Oncolytic Virus Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oncolytic Virus Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oncolytic Virus Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oncolytic Virus Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oncolytic Virus Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oncolytic Virus Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oncolytic Virus Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Oncolytic Virus Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Oncolytic Virus Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Oncolytic Virus Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of Takara Bio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takara Bio

    • Figure Sales and Growth Rate Analysis of Takara Bio

    • Figure Revenue and Market Share Analysis of Takara Bio

    • Table Product and Service Introduction of Takara Bio

    • Table Company Profile and Development Status of Theravir

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Theravir

    • Figure Sales and Growth Rate Analysis of Theravir

    • Figure Revenue and Market Share Analysis of Theravir

    • Table Product and Service Introduction of Theravir

    • Table Company Profile and Development Status of Otsuka Pharmaceutical Co

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Otsuka Pharmaceutical Co

    • Figure Sales and Growth Rate Analysis of Otsuka Pharmaceutical Co

    • Figure Revenue and Market Share Analysis of Otsuka Pharmaceutical Co

    • Table Product and Service Introduction of Otsuka Pharmaceutical Co

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of SillaJen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SillaJen

    • Figure Sales and Growth Rate Analysis of SillaJen

    • Figure Revenue and Market Share Analysis of SillaJen

    • Table Product and Service Introduction of SillaJen

    • Table Company Profile and Development Status of Latima

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Latima

    • Figure Sales and Growth Rate Analysis of Latima

    • Figure Revenue and Market Share Analysis of Latima

    • Table Product and Service Introduction of Latima

    • Table Company Profile and Development Status of Shanghai Sunway Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai Sunway Biotech

    • Figure Sales and Growth Rate Analysis of Shanghai Sunway Biotech

    • Figure Revenue and Market Share Analysis of Shanghai Sunway Biotech

    • Table Product and Service Introduction of Shanghai Sunway Biotech

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Genelux

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genelux

    • Figure Sales and Growth Rate Analysis of Genelux

    • Figure Revenue and Market Share Analysis of Genelux

    • Table Product and Service Introduction of Genelux

    • Table Company Profile and Development Status of Neotropix

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Neotropix

    • Figure Sales and Growth Rate Analysis of Neotropix

    • Figure Revenue and Market Share Analysis of Neotropix

    • Table Product and Service Introduction of Neotropix

    • Table Company Profile and Development Status of Cold Genesys

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cold Genesys

    • Figure Sales and Growth Rate Analysis of Cold Genesys

    • Figure Revenue and Market Share Analysis of Cold Genesys

    • Table Product and Service Introduction of Cold Genesys

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US